Insulin therapy in diabetes and cancer risk: current understanding and implications for future study: proceedings from a meeting of a European Insulin Safety Consensus Panel, convened and sponsored by Novo Nordisk, held Tuesday October 5, 2010 at The Radisson Edwardian Heathrow Hotel, Hayes, Middlesex, UK.

SC Gough; C Belda-Iniesta; C Poole; M Weber; D Russell-Jones; BF Hansen; E Mannucci; J Tuomilehto

doi:10.1007/s12325-011-0047-8

Back

Insulin therapy in diabetes and cancer risk: current understanding and implications for future study: proceedings from a meeting of a European Insulin Safety Consensus Panel, convened and sponsored by Novo Nordisk, held Tuesday October 5, 2010 at The Radisson Edwardian Heathrow Hotel, Hayes, Middlesex, UK.

Journal article

Peer reviewed

Insulin therapy in diabetes and cancer risk: current understanding and implications for future study: proceedings from a meeting of a European Insulin Safety Consensus Panel, convened and sponsored by Novo Nordisk, held Tuesday October 5, 2010 at The Radisson Edwardian Heathrow Hotel, Hayes, Middlesex, UK.

SC Gough, C Belda-Iniesta, C Poole, M Weber, D Russell-Jones, BF Hansen, E Mannucci and J Tuomilehto

Adv Ther, Vol.28 Sup, pp.1-18

09/2011

DOI: https://doi.org/10.1007/s12325-011-0047-8

Abstract

Diabetes Mellitus

Europe

Humans

Insulin

Neoplasms

Interest in the possibility of certain insulin treatments having the potential to modify cancer development and prognosis was reawakened in 2009, following publication of several epidemiological studies addressing this issue. This interest extends to how diabetes itself and cancer might be linked, and makes desirable an exchange of expert views and knowledge to enhance understanding in this subject among those treating diabetes and cancer, or those developing diabetes therapies.

Metrics

21 Record Views

See more details

Details

Title: Insulin therapy in diabetes and cancer risk: current understanding and implications for future study: proceedings from a meeting of a European Insulin Safety Consensus Panel, convened and sponsored by Novo Nordisk, held Tuesday October 5, 2010 at The Radisson Edwardian Heathrow Hotel, Hayes, Middlesex, UK.
Creators: SC Gough
C Belda-Iniesta
C Poole
M Weber
D Russell-Jones
BF Hansen
E Mannucci
J Tuomilehto
Publication Details: Adv Ther, Vol.28 Sup, pp.1-18
Date published: 09/2011
Date submitted: 17/05/2017
Identifiers: 99513700002346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article

Abstract

Metrics

Details

Usage Policy